Therapeutic vaccines: advances in understanding of appropriate patient selection and trial design

Dr James Gulley, Director, Clinical Trials Group & Deputy Chief, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health joined us at the World Vaccine Congress Washington to lead the discussion of appropriate patient selection and trial design in the production of therapeutic vaccines.  His conclusions included: • Appropriate endpoints      – Kinetics …